CN114376772A - Interbody fusion cage and method of use - Google Patents
Interbody fusion cage and method of use Download PDFInfo
- Publication number
- CN114376772A CN114376772A CN202011139958.0A CN202011139958A CN114376772A CN 114376772 A CN114376772 A CN 114376772A CN 202011139958 A CN202011139958 A CN 202011139958A CN 114376772 A CN114376772 A CN 114376772A
- Authority
- CN
- China
- Prior art keywords
- auxiliary groove
- accommodating part
- hole
- adsorption layer
- bracket
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 11
- 230000004927 fusion Effects 0.000 title abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 49
- 239000003814 drug Substances 0.000 claims abstract description 49
- 238000001179 sorption measurement Methods 0.000 claims abstract description 40
- 230000008468 bone growth Effects 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 10
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 13
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 13
- 229940112869 bone morphogenetic protein Drugs 0.000 claims description 13
- 210000000130 stem cell Anatomy 0.000 claims description 13
- 230000007480 spreading Effects 0.000 claims description 10
- 238000009434 installation Methods 0.000 claims description 9
- 230000001737 promoting effect Effects 0.000 claims description 6
- 210000000988 bone and bone Anatomy 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 3
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 238000002513 implantation Methods 0.000 abstract description 6
- 238000010883 osseointegration Methods 0.000 abstract description 5
- 230000002980 postoperative effect Effects 0.000 abstract description 5
- 230000000740 bleeding effect Effects 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 4
- 208000014674 injury Diseases 0.000 abstract description 3
- 230000008733 trauma Effects 0.000 abstract description 3
- 238000010586 diagram Methods 0.000 description 11
- 238000013459 approach Methods 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical group [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/4455—Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30621—Features concerning the anatomical functioning or articulation of the prosthetic joint
- A61F2002/30622—Implant for fusing a joint or bone material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2002/30733—Inserts placed into an endoprosthetic cavity, e.g. for modifying a material property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
Abstract
本发明提供一种椎间融合器及其使用方法,包括:容纳部,所述容纳部可撑开,所述容纳部上设有开口,所述容纳部的外侧面上包覆有药物吸附层,所述药物吸附层的材料为医用凝胶;所述药物吸附层所吸附的药物为能够吸附促进骨生长的物质。本发明的椎间融合器具有可以微创植入,骨结合能力好,融合更彻底,术后即时稳定性好,创伤小、出血少、术后恢复快等优点。
The present invention provides an intervertebral fusion cage and a method of using the same, comprising: a accommodating part, the accommodating part can be stretched, the accommodating part is provided with an opening, and the outer surface of the accommodating part is covered with a drug adsorption layer , the material of the drug adsorption layer is medical gel; the drug adsorbed by the drug adsorption layer is a substance that can adsorb and promote bone growth. The intervertebral fusion device of the invention has the advantages of minimally invasive implantation, good osseointegration ability, more complete fusion, good immediate postoperative stability, less trauma, less bleeding, and quick postoperative recovery.
Description
技术领域technical field
本发明涉及植入器械技术领域,特别是涉及一种椎间融合器及其使用方法。The present invention relates to the technical field of implanted instruments, in particular to an intervertebral cage and a method of using the same.
背景技术Background technique
在常见的椎间融合手术中,椎间融合器是当前椎间融合手术最常用的装置。根据其手术入路不同,后方入路常用子弹头型融合器;侧后方入路常用肾型融合器;前方入路和侧前方入路用楔形融合器。当前的融合器材料为聚醚醚酮,它的骨结合能力差,植入体内之后,聚醚醚酮本身不会有骨长入,所以后期的融合主要靠植骨。另外,由于微创手术具有切口小、软组织损伤小、出血少、术后康复快等优点成为当前脊柱外科手术的热门发展方向。如何涉及一种骨结合能力好,可以微创植入的椎间融合器是本领域技术人员需要解决的问题。In the common interbody fusion surgery, the interbody cage is the most commonly used device in the current interbody fusion surgery. According to the different surgical approaches, bullet-shaped cages are commonly used for the posterior approach; renal-type cages are commonly used for the lateral-posterior approach; and wedge-shaped cages are used for the anterior approach and the lateral-anterior approach. The current cage material is polyetheretherketone, which has poor osseointegration ability. After implantation, polyetheretherketone itself will not have bone ingrowth, so the later fusion mainly relies on bone grafting. In addition, minimally invasive surgery has the advantages of small incision, small soft tissue damage, less bleeding, and quick postoperative recovery, which has become a popular development direction of current spine surgery. How to relate to an intervertebral cage with good osseointegration ability and minimally invasive implantation is a problem to be solved by those skilled in the art.
发明内容SUMMARY OF THE INVENTION
鉴于以上所述现有技术的缺点,本发明解决的技术问题在于提供一种的椎间融合器。In view of the above-mentioned shortcomings of the prior art, the technical problem solved by the present invention is to provide an intervertebral cage.
为实现上述目的及其他相关目的,本发明提供一种椎间融合器,包括:容纳部,所述容纳部可撑开,所述容纳部上设有开口,所述容纳部的外侧面上包覆有药物吸附层。In order to achieve the above object and other related objects, the present invention provides an intervertebral cage, comprising: a accommodating part, the accommodating part can be stretched, the accommodating part is provided with an opening, and the outer side of the accommodating part is covered with Covered with a drug adsorption layer.
优选地,所述药物吸附层的材料为医用凝胶。Preferably, the material of the drug adsorption layer is medical gel.
进一步地,所述药物吸附层所吸附的药物为能够吸附促进骨生长的药物。Further, the drug adsorbed by the drug adsorption layer is a drug capable of adsorbing and promoting bone growth.
本发明还涉及一种椎间融合器,包括:容纳部,所述容纳部可撑开,所述容纳部上设有开口,所述容纳部的外侧面上包覆有药物吸附层,所述药物吸附层的材料为医用凝胶;所述药物吸附层所吸附的药物为能够吸附促进骨生长的药物。The present invention also relates to an intervertebral cage, comprising: an accommodating part, the accommodating part can be stretched, an opening is provided on the accommodating part, the outer surface of the accommodating part is covered with a drug adsorption layer, and the The material of the drug adsorption layer is medical gel; the drug adsorbed by the drug adsorption layer is a drug capable of adsorbing and promoting bone growth.
优选地,所述药物吸附层所吸附的药物为骨形态发生蛋白或者干细胞。Preferably, the drug adsorbed by the drug adsorption layer is bone morphogenetic protein or stem cells.
优选地,所述容纳部为囊袋。Preferably, the accommodating portion is a pouch.
优选地,所述的椎间融合器,还包括连接杆,所述连接杆的一端与所述开口连接,沿着所述连接杆的轴向设有中间通孔,所述中间通孔与所述开口连通。Preferably, the intervertebral cage further includes a connecting rod, one end of the connecting rod is connected to the opening, and a middle through hole is provided along the axial direction of the connecting rod, and the middle through hole is connected to the opening. The opening is connected.
优选地,所述的椎间融合器,还包括撑开支架,所述撑开支架可插入于所述容纳部中;所述撑开支架包括:支架主体和支撑杆;Preferably, the intervertebral cage further includes a spreader bracket, which can be inserted into the accommodating portion; the spreader bracket includes: a bracket main body and a support rod;
所述支架主体为长条状结构,所述支架主体的外周侧面包括依次连接的第一开槽面、第一支撑面、第二开槽面和第二支撑面;所述第一开槽面与所述第二开槽面相对设置;所述第一支撑面与所述第二支撑面相对设置;The bracket body is a long strip structure, and the outer peripheral side surface of the bracket body includes a first slotted surface, a first support surface, a second slotted surface and a second support surface connected in sequence; the first slotted surface opposite to the second slotted surface; the first support surface and the second support surface are arranged opposite;
所述支架主体在长度方向上的前端上设有安装部,所述支架主体在长度方向上的后端上设有驱动部;The front end of the bracket body in the longitudinal direction is provided with a mounting portion, and the rear end of the bracket body in the longitudinal direction is provided with a driving portion;
所述支架主体上设有贯通孔,所述贯通孔的两端分别贯通至所述安装部的前端和所述驱动部的后端,所述贯通孔的轴向与所述支架主体的长度方向同向;The bracket body is provided with a through hole, two ends of the through hole respectively penetrate to the front end of the mounting part and the rear end of the driving part, and the axial direction of the through hole is the same as the length direction of the bracket body. In the same direction;
所述支撑杆依次穿过所述安装部、所述支架主体和所述驱动部,所述支撑杆与所述贯通孔为间隙配合,所述支撑杆与所述安装部固定连接;所述支撑杆具有中空通道,所述中空通道贯通至所述支撑杆的后端;The support rod passes through the installation part, the bracket main body and the driving part in sequence, the support rod and the through hole are in clearance fit, and the support rod is fixedly connected with the installation part; the support rod The rod has a hollow channel, and the hollow channel penetrates to the rear end of the support rod;
在所述第一开槽面上的宽度方向上的中部具有中间长条槽,所述中间长条槽贯通至所述第二开槽面,所述中间长条槽的长度方向与所述第一开槽面的长度方向同向;The middle part of the first grooved surface in the width direction has a middle long groove, the middle long groove penetrates to the second grooved surface, and the length direction of the middle long groove is the same as that of the first grooved surface. The length direction of a slotted surface is in the same direction;
沿着所述第一开槽面上的宽度方向,在所述中间长条槽的两侧分别设有第一辅助槽组和第二辅助槽组;所述第一辅助槽组和所述第二辅助槽组的结构相同,所述第一辅助槽组包括沿着所述第一开槽面上的长度方向依次设置的前端辅助槽和后端辅助槽,所述前端辅助槽和所述后端辅助槽之间具有间隔,所述前端辅助槽的后端与所述后端辅助槽的前端之间的连线的中点连接所述中间长条槽的长度的中点的连线与所述支架主体的宽度方向同向;Along the width direction of the first slotted surface, a first auxiliary slot group and a second auxiliary slot group are respectively provided on both sides of the middle elongated slot; the first auxiliary slot group and the first auxiliary slot group are respectively provided. The structures of the two auxiliary groove groups are the same. The first auxiliary groove group includes a front-end auxiliary groove and a rear-end auxiliary groove arranged in sequence along the length direction of the first slotted surface. There is a space between the end auxiliary grooves, and the midpoint of the connection line between the rear end of the front end auxiliary groove and the front end of the rear end auxiliary groove connects the connection line of the midpoint of the length of the middle elongated groove and the end point. The width directions of the main body of the bracket are in the same direction;
所述第一支撑面通过第一连接块与第一支撑板连接;所述第二支撑面通过第二连接块与第二支撑板连接;The first support surface is connected with the first support plate through a first connection block; the second support surface is connected with the second support plate through a second connection block;
所述支撑杆的外侧壁上具有侧壁通孔,所述侧壁通孔与所述中空通道连通,所述侧壁通孔处于所述贯通孔与所述中间长条槽连通所构成的主腔室中,且将所述支架主体的前端和后端相比较,所述侧壁通孔较靠近所述支架主体的前端;The outer side wall of the support rod is provided with a side wall through hole, the side wall through hole communicates with the hollow channel, and the side wall through hole is in the main part formed by the communication between the through hole and the middle elongated slot. in the chamber, and comparing the front end and the rear end of the bracket body, the side wall through hole is closer to the front end of the bracket body;
顶住所述支撑杆的前端,推动所述驱动部向着靠近所述安装部的方向移动,所述支架主体伸展为六边形结构。The front end of the support rod is pressed to push the driving part to move toward the direction close to the installation part, and the bracket body extends into a hexagonal structure.
优选地,所述的椎间融合器,还包括撑开部件,所述撑开部件为弹性板件,所述弹性板件卷曲回转形成由内至外依次环绕的多个圈层结构,所有圈层结构的中轴线共线。Preferably, the intervertebral cage further includes a spreading member, the spreading member is an elastic plate member, and the elastic plate member is curled and turned to form a plurality of ring-layer structures that are sequentially surrounded from the inside to the outside. The central axis of the layer structure is collinear.
本发明还涉及一种椎间融合器的使用方法,将权利要求中所述的椎间融合器的药物吸附层浸泡在骨形态发生蛋白或者干细胞中,使得所述药物吸附层吸附骨形态发生蛋白或者干细胞。The present invention also relates to a method for using an intervertebral cage. The drug adsorption layer of the intervertebral cage described in the claims is soaked in bone morphogenetic protein or stem cells, so that the drug adsorption layer adsorbs the bone morphogenetic protein. or stem cells.
如上所述,本发明的椎间融合器及其使用方法,具有以下有益效果:As mentioned above, the intervertebral cage of the present invention and its using method have the following beneficial effects:
本发明的椎间融合器中,容纳部在未撑开时进入人体,当容纳部达到椎体之间后,容纳部再撑开;则该椎间融合器可以微创手术的方式经小通道植入中;容纳部的外侧面上包覆有药物吸附层,药物吸附层在术前浸入促进骨生长的物质中,则药物吸附层能够吸附促进骨生长的物质;待容纳部在椎体之间撑开后,药物吸附层能够附着在椎体之间,药物吸附层上的促进骨生长的物质能够提高骨的结合能力;本发明为一种带涂层的椎间融合装置,本发明的椎间融合器具有可以微创植入,骨结合能力好,融合更彻底,术后即时稳定性好,创伤小、出血少、术后恢复快等优点。In the intervertebral cage of the present invention, the accommodating part enters the human body when it is not stretched, and when the accommodating part reaches between the vertebral bodies, the accommodating part is stretched again; then the intervertebral cage can be operated through a small channel in a minimally invasive manner During implantation; the outer surface of the accommodating part is covered with a drug adsorption layer, and the drug adsorption layer is immersed in the substance that promotes bone growth before operation, and the drug adsorption layer can absorb the substance that promotes bone growth; After the intervertebral space is opened, the drug adsorption layer can be attached between the vertebral bodies, and the bone growth-promoting substance on the drug adsorption layer can improve the binding ability of the bone; the present invention is a coated intervertebral fusion device, and the The intervertebral cage has the advantages of minimally invasive implantation, good osseointegration, more complete fusion, good immediate stability after surgery, less trauma, less bleeding, and faster postoperative recovery.
附图说明Description of drawings
图1显示为实施例1的椎间融合器插入椎体之间的结构示意图。Fig. 1 is a schematic diagram showing the structure of the intervertebral cage inserted between the vertebral bodies of Example 1.
图2显示为实施例1的椎间融合器的立体结构示意图。FIG. 2 is a schematic diagram of the three-dimensional structure of the interbody cage of Example 1. FIG.
图3显示为实施例1的椎间融合器的内部结构示意图。FIG. 3 is a schematic diagram showing the internal structure of the interbody cage of Example 1. FIG.
图4显示为实施例2的椎间融合器的容纳部的内部插入撑开支架时的结构示意图。FIG. 4 is a schematic diagram showing the structure of the accommodating part of the intervertebral cage of Example 2 when a distraction bracket is inserted.
图5显示为实施例2的椎间融合器的撑开支架处于初始状态的侧面立体结构示意图。FIG. 5 is a schematic side view of the three-dimensional structure of the distraction bracket of the intervertebral cage of Example 2 in an initial state.
图6显示为实施例2的椎间融合器的撑开支架处于初始状态的前侧立体结构示意图。FIG. 6 is a schematic diagram showing the front side three-dimensional structure of the distraction bracket of the intervertebral cage of Example 2 in an initial state.
图7显示为实施例2的椎间融合器的撑开支架处于初始状态的后侧立体结构示意图。FIG. 7 is a schematic diagram showing the rear side three-dimensional structure of the distraction bracket of the intervertebral cage of Example 2 in an initial state.
图8显示为实施例2的椎间融合器的撑开支架处于初始状态的侧面结构示意图。FIG. 8 is a schematic side view of the structure of the distraction bracket of the intervertebral cage of Example 2 in an initial state.
图9显示为图8的A-A剖面结构示意图。FIG. 9 is a schematic diagram showing the cross-sectional structure of A-A of FIG. 8 .
图10显示为实施例2的椎间融合器的撑开支架的支架主体处于初始状态的侧面结构示意图。FIG. 10 is a schematic side view of the structure of the stent body of the distracting stent of the intervertebral cage of Example 2 in an initial state.
图11显示为图10的B-B剖面结构示意图。FIG. 11 is a schematic diagram of the cross-sectional structure taken along the line B-B of FIG. 10 .
图12显示为实施例2的椎间融合器的撑开支架的支撑杆的立体结构示意图。FIG. 12 is a schematic three-dimensional structural diagram of the support rod of the distraction bracket of the intervertebral cage of Example 2. FIG.
图13显示为实施例2的椎间融合器的撑开支架的处于展开状态的立体侧面结构示意图。FIG. 13 is a schematic three-dimensional side structure view of the distraction bracket of the intervertebral cage of Example 2 in a deployed state.
图14显示为实施例3的椎间融合器的撑开部件的处于收紧状态的立体结构示意图。FIG. 14 is a schematic three-dimensional structural diagram of the distraction component of the intervertebral cage of Example 3 in a tightened state.
图15显示为实施例3的椎间融合器的撑开部件的处于舒展状态的立体结构示意图。FIG. 15 is a schematic three-dimensional structural diagram of the distraction component of the interbody cage of Example 3 in a stretched state.
附图标号说明Explanation of reference numerals
10 容纳部10 Housing
11 开口11 opening
20 药物吸附层20 Drug adsorption layer
30 连接杆30 connecting rod
31 中间通孔31 Middle through hole
100 支架主体100 Bracket body
101 第一开槽面101 First grooved surface
102 第一支撑面102 First support surface
103 第二开槽面103 Second grooved surface
104 第二支撑面104 Second support surface
110 安装部110 Installation part
111 前缩结构111 Front indentation structure
120 驱动部120 Drive
121 卡槽121 card slot
130 贯通孔130 Through hole
140 中间长条槽140 Middle slot
150 第一辅助槽组150 First Auxiliary Slot Group
151 前端辅助槽151 Front Auxiliary Slot
152 后端辅助槽152 Rear auxiliary slot
153 前槽部前凹陷结构153 Front recessed structure of front groove
154 前槽部后凹陷结构154 Front groove rear recessed structure
155 后槽部前凹陷结构155 Front recessed structure of rear groove
156 后槽部后凹陷结构156 Rear recessed structure of the rear groove
160 第二辅助槽组160 Second auxiliary slot group
171 第一连接块171 First connection block
172 第二连接块172 Second connection block
181 第一支撑板181 First support plate
182 第二支撑板182 Second support plate
183 第一斜面183 First Bevel
184 第二斜面184 Second slope
200 支撑杆200 support rod
210 中空通道210 Hollow channel
220 侧壁通孔220 Sidewall Through Holes
230 内连接部230 inner connector
240 外连接部240 Outer connector
300 撑开部件300 spread parts
310 圈层结构310 Circle Structure
具体实施方式Detailed ways
以下由特定的具体实施例说明本发明的实施方式,熟悉此技术的人士可由本说明书所揭露的内容轻易地了解本发明的其他优点及功效。The embodiments of the present invention are described below by specific embodiments, and those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification.
请参阅附图。须知,本说明书所附图式所绘示的结构、比例、大小等,均仅用以配合说明书所揭示的内容,以供熟悉此技术的人士了解与阅读,并非用以限定本发明可实施的限定条件,故不具技术上的实质意义,任何结构的修饰、比例关系的改变或大小的调整,在不影响本发明所能产生的功效及所能达成的目的下,均应仍落在本发明所揭示的技术内容得能涵盖的范围内。同时,本说明书中所引用的如“上”、“下”、“左”、“右”、“中间”及“一”等的用语,亦仅为便于叙述的明了,而非用以限定本发明可实施的范围,其相对关系的改变或调整,在无实质变更技术内容下,当亦视为本发明可实施的范畴。Please see attached image. It should be noted that the structures, proportions, sizes, etc. shown in the drawings in this specification are only used to cooperate with the contents disclosed in the specification, so as to be understood and read by those who are familiar with the technology, and are not used to limit the implementation of the present invention. Restricted conditions, it does not have technical substantive significance, any structural modification, proportional relationship change or size adjustment, without affecting the effect that the present invention can produce and the purpose that can be achieved, should still fall within the present invention. The disclosed technical content must be within the scope of coverage. At the same time, the terms such as "up", "down", "left", "right", "middle" and "one" quoted in this specification are only for the convenience of description and clarity, and are not used to limit this specification. The implementable scope of the invention, and the change or adjustment of the relative relationship thereof, shall also be regarded as the implementable scope of the present invention without substantially changing the technical content.
实施例1Example 1
如图1至图3所示,本实施例的椎间融合器,包括:容纳部10,容纳部10可撑开,容纳部10上设有开口11,容纳部10的外侧面上包覆有药物吸附层20,药物吸附层20的材料为医用凝胶。As shown in FIG. 1 to FIG. 3 , the intervertebral cage of this embodiment includes: an
本发明的椎间融合器中,容纳部10在未撑开时进入人体,当容纳部10达到椎体之间后,容纳部10再撑开;则该椎间融合器可以微创手术的方式经小通道植入中;容纳部10的外侧面上包覆有药物吸附层20,药物吸附层20的材料为医用凝胶,药物吸附层20在术前浸入促进骨生长的物质中,则药物吸附层20能够吸附促进骨生长的物质;待容纳部10在椎体之间撑开后,药物吸附层20能够附着在椎体之间,药物吸附层20上的促进骨生长的物质能够提高骨的结合能力;本发明为一种带涂层的椎间融合装置,本发明的椎间融合器具有可以微创植入,骨结合能力好,融合更彻底,术后即时稳定性好,创伤小、出血少、术后恢复快等优点。本发明的椎间融合器可应用于椎间盘镜手术中。本实施例中的医用凝胶的材料为透明质酸钠。药物吸附层20所吸附的药物为能够吸附促进骨生长的物质。本实施例中,药物吸附层20所的能够吸附促进骨生长的物质为骨形态发生蛋白或者干细胞。In the intervertebral cage of the present invention, the
容纳部10为囊袋。通过囊袋的开口11,对囊袋中通入生理盐水或者充入气体即可使囊袋撑开。The
本实施例的椎间融合器的使用方法,包括以下步骤:The method of using the intervertebral cage of the present embodiment includes the following steps:
1)将椎间融合器的药物吸附层20浸泡在骨形态发生蛋白或者干细胞中,使得所述药物吸附层20吸附骨形态发生蛋白或者干细胞;1) soaking the
2)当容纳部10达到椎体之间后,对囊袋中通入生理盐水或者充入气体,使囊袋被撑开。2) After the
实施例2Example 2
如图4至图13所示,本实施例中,椎间融合器,还包括连接杆30,连接杆30的一端与开口11连接,沿着连接杆30的轴向设有中间通孔31,中间通孔31与开口11连通。连接杆30的设置使得椎间融合器的结构更稳定,更易于操作。As shown in FIGS. 4 to 13 , in this embodiment, the intervertebral cage further includes a connecting
椎间融合器,还包括撑开支架,撑开支架可插入于容纳部10中;撑开支架可插入于容纳部10中;撑开支架包括:支架主体100和支撑杆200,支架主体100和支撑杆200均采用钛制成;支架主体100为长条状结构,支架主体100的外周侧面包括依次连接的第一开槽面101、第一支撑面102、第二开槽面103和第二支撑面104;第一开槽面101与第二开槽面103相对设置;第一支撑面102与第二支撑面104相对设置;The intervertebral cage also includes a spreader bracket, which can be inserted into the
支架主体100在长度方向上的前端上设有安装部110,支架主体100在长度方向上的后端上设有驱动部120;A mounting
支架主体100上设有贯通孔130,贯通孔130的两端分别贯通至安装部110的前端和驱动部120的后端,贯通孔130的轴向与支架主体100的长度方向同向;The bracket
支撑杆200依次穿过安装部110、支架主体100和驱动部120,支撑杆200与贯通孔130为间隙配合,支撑杆200与安装部110固定连接;支撑杆200具有中空通道210,中空通道210贯通至支撑杆200的后端;中空通道210的轴向与支撑杆200的轴向同向;The
在第一开槽面101上的宽度方向上的中部具有中间长条槽140,中间长条槽140贯通至第二开槽面103,中间长条槽140的长度方向与第一开槽面101的长度方向同向;There is a middle
沿着第一开槽面101上的宽度方向,在中间长条槽140的两侧分别设有第一辅助槽组150和第二辅助槽组160;第一辅助槽组150和第二辅助槽组160的结构相同,第一辅助槽组150包括沿着第一开槽面101上的长度方向依次设置的前端辅助槽151和后端辅助槽152,前端辅助槽151和后端辅助槽152之间具有间隔,前端辅助槽151的后端与后端辅助槽152的前端之间的连线的中点连接中间长条槽140的长度的中点的连线为中间连线,该中间连线与支架主体100的宽度W2方向同向;Along the width direction of the first slotted
第一支撑面102通过第一连接块171与第一支撑板181连接;第二支撑面104通过第二连接块172与第二支撑板182连接;The
支撑杆200的外侧壁上具有侧壁通孔220,侧壁通孔220与中空通道210连通,侧壁通孔220处于贯通孔130与中间长条槽140连通所构成的主腔室中,且将支架主体100的前端和后端相比较,侧壁通孔220较靠近支架主体100的前端;The outer side wall of the
顶住支撑杆200的前端,推动驱动部120向着靠近安装部110的方向移动,支架主体100伸展为六边形结构。The front end of the
本实施例的撑开支架使用时,未撑开的撑开支架设置于未撑开的容纳部10中,当需要撑开容纳部10时,顶住支撑杆200的前端,推动驱动部120向着靠近安装部110的方向移动,支架主体100伸展为六边形结构。本实施例的撑开支架采用钛材料制成,钛材料的使用能够保证有足够的强度维持椎体正常形态。撑开支架用于撑开容纳部。When the spreader bracket of this embodiment is used, the unstretched spreader bracket is arranged in the unstretched
第一开槽面101、第一支撑面102、第二开槽面103和第二支撑面104均为平面;第一开槽面101与第二开槽面103相对且平行设置;第一支撑面102与第二支撑面104相对且平行设置;第一支撑面102与第一支撑板181的外侧面平行,第二支撑面104与第二支撑板182的外侧面平行。The first slotted
由于在中间长条槽140的两侧分别设有第一辅助槽组150和第二辅助槽组160;第一辅助槽组150和第二辅助槽组160的结构相同,第一辅助槽组150包括沿着第一开槽面101上的长度方向依次设置的前端辅助槽151和后端辅助槽152,该结构便于支架主体100伸展开。Because the first
第一支撑面102通过第一连接块171与第一支撑板181连接;第二支撑面104通过第二连接块172与第二支撑板182连接,该结构使得第一支撑面102与第一支撑板181之间不接触,第二支撑面104与第二支撑板182之间不接触,则支架主体100伸展开时,第一支撑板181和第二支撑板182能够实现稳定地支撑力。The
由于前端辅助槽151和后端辅助槽152之间具有间隔,前端辅助槽151的后端与后端辅助槽152的前端之间的连线的中点连接中间长条槽140的长度的中点的连线与支架主体100的宽度W2方向同向。该结构便于支架主体100伸展开形成六边形结构。Since there is a space between the front end
通过前端辅助槽151的后端与后端辅助槽152的前端之间的连线的中点且垂直于支架主体100的长度方向的平面为支架主体100的竖向中间平面,第一连接块171的在长度方向上的两端与竖向中间平面的距离相等,第二连接块172的在长度方向上的两端与竖向中间平面的距离相等。前端辅助槽151与后端辅助槽152之间的间隔的长度方向上的中部的位置与第一连接块171的长度方向上的中部的位置相应;前端辅助槽151与后端辅助槽152之间的间隔的长度方向上的中部的位置与第二连接块172的长度方向上的中部的位置相应;由于第一连接块171增强了第一辅助槽组150的前端辅助槽151与后端辅助槽152之间的间隔处的强度,则有利于第一辅助槽组150的前端辅助槽151与后端辅助槽152之间的间隔处能够在支架主体100伸展为六边形结构的过程中,作为六边形结构的其中一条边;由于第二连接块172增强了第二辅助槽组160的前端辅助槽151与后端辅助槽152之间的间隔处的强度,则有利于第二辅助槽组160的前端辅助槽151与后端辅助槽152之间的间隔处能够在支架主体100伸展为六边形结构的过程中,作为六边形结构的其中一条边。The plane passing through the midpoint of the line between the rear end of the front end
第一支撑板181的在长度方向上的两端与竖向中间平面的距离相等,第二支撑板182的在长度方向上的两端与竖向中间平面的距离相等。该结构使得第一支撑板181和第二支撑板182受到稳定的支撑力。Both ends of the
第一支撑板181与第二支撑板182的宽度相等,支架主体100的宽度W2小于等于第一支撑板181的宽度。本实施例中,支架主体100的宽度W2等于第一支撑板181的宽度。该结构使得第一支撑板181与第二支撑板182具有较好的支撑力。The widths of the
第一支撑板181的外侧面与第二支撑板182的外侧面平行;第一支撑板181的外侧面与第二支撑板182的外侧面之间的距离为图8的H所示。The outer surface of the
安装部110的前部为向前收缩的前缩结构111,前缩结构111的前端的圆弧形端面。该结构使得安装部110的前部形成子弹头的形状,便于插入安装。The front part of the
前缩结构111的外侧面上具有两个相对设置的前缩部斜面1111;第一支撑板181的外侧面的前部为向着支架主体100倾斜设置的第一斜面183,第二支撑板182的外侧面的前部为向着支架主体100倾斜设置的第二斜面184;第一斜面183与其中一个前缩部斜面1111共面,第二斜面184与另一个前缩部斜面1111共面,以便于插入囊袋中。The outer side of the
支撑杆200的中空通道210的前端上设有供前部定位器具连接的内连接部230。前部定位器具通过与内连接部230的连接,将支撑杆200的前端的位置固定,即前部定位器具顶住支撑杆200的前端。The front end of the
本实施例中,内连接部230为内螺纹。前部定位器具为具有与内连接部230的内螺纹相应的外螺纹的医用定位器具。In this embodiment, the inner connecting
驱动部120上设有卡槽121。卡槽121可供推动驱动部120的医用工具卡入,便于推动驱动部120。The driving
本实施例中,驱动部120为圆柱形。该结构使得驱动部120能够被稳定地推动。In this embodiment, the driving
第一支撑板181和第二支撑板182结构相同,第一支撑板181的宽度W1能够提供较大的支撑面,稳定地支撑椎体。The
每个前端辅助槽151的槽壁的前部设有前槽部前凹陷结构153,每个前端辅助槽151的槽壁的后部设有前槽部后凹陷结构154;每个后端辅助槽152的槽壁的前部设有后槽部前凹陷结构155,每个后端辅助槽152的槽壁的后部设有后槽部后凹陷结构156。The front part of the groove wall of each front end
前槽部前凹陷结构153包括两个相对设置于前端辅助槽151的槽壁的前部的第一前凹陷部,前槽部后凹陷结构154包括两个相对设置于前端辅助槽151的槽壁的后部的第一后凹陷部;后槽部前凹陷结构155包括两个相对设置于后端辅助槽152的槽壁的前部的第二前凹陷部;后槽部后凹陷结构156包括两个相对设置于后端辅助槽152的槽壁的后部的第二后凹陷部。The front recessed
本实施例的椎间融合器的使用方法,包括以下步骤:The method of using the intervertebral cage of the present embodiment includes the following steps:
1)将椎间融合器的药物吸附层20浸泡在骨形态发生蛋白或者干细胞中,使得所述药物吸附层20吸附骨形态发生蛋白或者干细胞;1) soaking the
2)当容纳部10达到椎体之间后,顶住支撑杆200的前端,推动驱动部120向着靠近安装部110的方向移动,支架主体100伸展为六边形结构,使容纳部10被撑开。2) When the
实施例3Example 3
如图3、图14至图15所示,本实施例中,椎间融合器,还包括撑开部件300,所述撑开部件300为弹性板件,所述弹性板件卷曲回转形成由内至外依次环绕的多个圈层结构310,所有圈层结构310的中轴线共线。撑开部件300初始时,撑开部件300是收紧状态;当需要撑开部件300将容纳部10撑开时,驱动撑开部件300,使得撑开部件300处于舒展状态,则撑开部件300舒展为单个环绕圈层。As shown in FIGS. 3 , 14 to 15 , in this embodiment, the intervertebral cage further includes a spreading
本实施例的椎间融合器的使用方法,包括以下步骤:The method of using the intervertebral cage of the present embodiment includes the following steps:
1)将椎间融合器的药物吸附层20浸泡在骨形态发生蛋白或者干细胞中,使得所述药物吸附层20吸附骨形态发生蛋白或者干细胞;1) soaking the
2)当容纳部10达到椎体之间后,驱动撑开部件300,使得撑开部件300舒展,撑开部件300舒展为单个环绕圈层,撑开部件300将容纳部10撑开。2) After the
综上,本发明有效克服了现有技术中的种种缺点而具高度产业利用价值。To sum up, the present invention effectively overcomes various shortcomings in the prior art and has high industrial utilization value.
上述实施例仅例示性说明本发明的原理及其功效,而非用于限制本发明。任何熟悉此技术的人士皆可在不违背本发明的精神及范畴下,对上述实施例进行修饰或改变。因此,举凡所属技术领域中具有通常知识者在未脱离本发明所揭示的精神与技术思想下所完成的一切等效修饰或改变,仍应由本发明的权利要求所涵盖。The above-mentioned embodiments merely illustrate the principles and effects of the present invention, but are not intended to limit the present invention. Anyone skilled in the art can make modifications or changes to the above embodiments without departing from the spirit and scope of the present invention. Therefore, all equivalent modifications or changes made by those with ordinary knowledge in the technical field without departing from the spirit and technical idea disclosed in the present invention should still be covered by the claims of the present invention.
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011139958.0A CN114376772A (en) | 2020-10-22 | 2020-10-22 | Interbody fusion cage and method of use |
CN202211329184.7A CN115531055A (en) | 2020-10-22 | 2020-10-22 | Interbody fusion cage and method of use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011139958.0A CN114376772A (en) | 2020-10-22 | 2020-10-22 | Interbody fusion cage and method of use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211329184.7A Division CN115531055A (en) | 2020-10-22 | 2020-10-22 | Interbody fusion cage and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114376772A true CN114376772A (en) | 2022-04-22 |
Family
ID=81194851
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211329184.7A Pending CN115531055A (en) | 2020-10-22 | 2020-10-22 | Interbody fusion cage and method of use |
CN202011139958.0A Pending CN114376772A (en) | 2020-10-22 | 2020-10-22 | Interbody fusion cage and method of use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211329184.7A Pending CN115531055A (en) | 2020-10-22 | 2020-10-22 | Interbody fusion cage and method of use |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN115531055A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115531055A (en) * | 2020-10-22 | 2022-12-30 | 上海三友医疗器械股份有限公司 | Interbody fusion cage and method of use |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5102402A (en) * | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
CN1708327A (en) * | 2002-10-30 | 2005-12-14 | 生物休眠有限公司 | Device with an expandable portion for drug release |
CN101052427A (en) * | 2004-10-06 | 2007-10-10 | 拜克技术有限公司 | Transparent hyaluronic acid coated bone implanting appliance |
CN101130112A (en) * | 2002-09-20 | 2008-02-27 | 乌尔里希·施佩克 | Balloon catheter for drug delivery, method of making and use thereof |
CN201168075Y (en) * | 2008-03-21 | 2008-12-24 | 杨惠林 | Minimal invasion intervertebral fusion device |
CN101969888A (en) * | 2008-01-16 | 2011-02-09 | 华沙整形外科股份有限公司 | Joint replacement device |
CN102038563A (en) * | 2003-10-22 | 2011-05-04 | 先锋外科技术公司 | Artificial intervertebral disc device |
CN102341066A (en) * | 2008-12-31 | 2012-02-01 | 奥马尔·F·希门尼斯 | Method and apparatus for vertebral body distraction and fusion using curved members |
CN102596109A (en) * | 2009-09-17 | 2012-07-18 | 斯恩蒂斯有限公司 | Intervertebral implant having extendable bone fixation members |
CN103610523A (en) * | 2013-12-18 | 2014-03-05 | 广州聚生生物科技有限公司 | Minimally invasive lateral approach interbody fusion device |
CN105611900A (en) * | 2013-10-07 | 2016-05-25 | 华沙整形外科股份有限公司 | Spinal implant system and method for lumbar and lumbosacral fusion |
CN106726019A (en) * | 2017-02-06 | 2017-05-31 | 南京市第医院 | The minimally invasive fusion device of intervertebral spinal fusion nanometer biological glass coating |
CN107920846A (en) * | 2015-08-30 | 2018-04-17 | 摩根·帕卡德·洛里奥 | Expandable intervertebral fusion device with living hinge, system and method of manufacture |
CN108135710A (en) * | 2015-10-16 | 2018-06-08 | 华沙整形外科股份有限公司 | Expandable intervertebral implant system and method |
CN115531055A (en) * | 2020-10-22 | 2022-12-30 | 上海三友医疗器械股份有限公司 | Interbody fusion cage and method of use |
-
2020
- 2020-10-22 CN CN202211329184.7A patent/CN115531055A/en active Pending
- 2020-10-22 CN CN202011139958.0A patent/CN114376772A/en active Pending
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5102402A (en) * | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
CN101130112A (en) * | 2002-09-20 | 2008-02-27 | 乌尔里希·施佩克 | Balloon catheter for drug delivery, method of making and use thereof |
CN1708327A (en) * | 2002-10-30 | 2005-12-14 | 生物休眠有限公司 | Device with an expandable portion for drug release |
CN102038563A (en) * | 2003-10-22 | 2011-05-04 | 先锋外科技术公司 | Artificial intervertebral disc device |
CN101052427A (en) * | 2004-10-06 | 2007-10-10 | 拜克技术有限公司 | Transparent hyaluronic acid coated bone implanting appliance |
CN101969888A (en) * | 2008-01-16 | 2011-02-09 | 华沙整形外科股份有限公司 | Joint replacement device |
CN201168075Y (en) * | 2008-03-21 | 2008-12-24 | 杨惠林 | Minimal invasion intervertebral fusion device |
CN102341066A (en) * | 2008-12-31 | 2012-02-01 | 奥马尔·F·希门尼斯 | Method and apparatus for vertebral body distraction and fusion using curved members |
CN102596109A (en) * | 2009-09-17 | 2012-07-18 | 斯恩蒂斯有限公司 | Intervertebral implant having extendable bone fixation members |
CN105611900A (en) * | 2013-10-07 | 2016-05-25 | 华沙整形外科股份有限公司 | Spinal implant system and method for lumbar and lumbosacral fusion |
CN103610523A (en) * | 2013-12-18 | 2014-03-05 | 广州聚生生物科技有限公司 | Minimally invasive lateral approach interbody fusion device |
CN107920846A (en) * | 2015-08-30 | 2018-04-17 | 摩根·帕卡德·洛里奥 | Expandable intervertebral fusion device with living hinge, system and method of manufacture |
CN108135710A (en) * | 2015-10-16 | 2018-06-08 | 华沙整形外科股份有限公司 | Expandable intervertebral implant system and method |
CN106726019A (en) * | 2017-02-06 | 2017-05-31 | 南京市第医院 | The minimally invasive fusion device of intervertebral spinal fusion nanometer biological glass coating |
CN115531055A (en) * | 2020-10-22 | 2022-12-30 | 上海三友医疗器械股份有限公司 | Interbody fusion cage and method of use |
Also Published As
Publication number | Publication date |
---|---|
CN115531055A (en) | 2022-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7588591B2 (en) | Intervertebral implant | |
AU726872B2 (en) | Intervertebral implant | |
JP4204200B2 (en) | Expandable interbody fusion cage | |
ES2456949T3 (en) | Load-bearing synthetic mineral-collagen compounds for spinal implants | |
AU2002323425B8 (en) | Soft and calcified tissue implants | |
WO1995025487A1 (en) | Middle expanded, removable intervertebral disk stabilizer and method of lumbar intervertebral disk stabilization | |
US20150142114A1 (en) | Intervertebral Disk Cage and Stabilizer | |
US20020038123A1 (en) | Osteotomy implant | |
JP2011515193A (en) | Foldable devices placed on the spine and methods related thereto | |
US20110071571A1 (en) | Spinal Rod Insertion Method | |
US20210145602A1 (en) | Multi-layer osteoinductive, osteogenic, and osteoconductive carrier | |
WO2001028466A3 (en) | Methods and instrumentation for disc space distraction | |
JP2010512840A (en) | Intraocular lens insertion instrument and method of use | |
JP2015536774A (en) | Intervertebral fusion implant capable of lateral expansion | |
CN114376772A (en) | Interbody fusion cage and method of use | |
CN111358600A (en) | Self-locking intervertebral fusion device system under spinal endoscope | |
CN201168075Y (en) | Minimal invasion intervertebral fusion device | |
CN107854197B (en) | A cervical intervertebral fusion device | |
KR20200011636A (en) | Space expanding intervertebral fusion cage device | |
CN214157595U (en) | Intervertebral fusion device | |
CN114271998A (en) | Distractable intervertebral fusion device | |
CN106236330B (en) | Dypass waist Invasive lumbar fusion device | |
CN112107355A (en) | Cervical vertebra fixing device that opens door | |
CN114129314A (en) | Intervertebral implant capable of being expanded | |
CN210170235U (en) | Distracting fusion device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |